FDA Orange Book
Generic for Vasostrict
Vasostrict contains vasopressin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Vasostrict is vasopressin. 8 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP. Generics match 4 of the 6 Vasostrict products the Orange Book lists.
Run it in Rivvi
Map Vasostrict and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vasostrict products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 200UNITS/10ML (20UNITS/ML) | Marketed (Rx) | AP | 1 | AP |
| solution, intravenous | 20UNITS/100ML (0.2UNITS/ML) | Marketed (Rx) | AP | 1 | AP |
| solution, intravenous | 20UNITS/ML (20UNITS/ML) | Marketed (Rx) | AP | 7 | AP |
| solution, intravenous | 40UNITS/100ML (0.4UNITS/ML) | Marketed (Rx) | AP | 2 | AP |
| solution, intravenous | 50UNITS/50ML (1UNITS/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 60UNITS/100ML (0.6UNITS/ML) | Discontinued | None | 0 | None |
NDA 204485, held by PH HEALTH LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic vasopressin
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AMPHASTAR PHARMACEUTICALS INC | 211857 | AP (A-rated, therapeutically equivalent) | July 18, 2022 | 20UNITS/ML (20UNITS/ML) |
| AMNEAL EU LTD | 212944 | AP (A-rated, therapeutically equivalent) | August 5, 2022 | 20UNITS/ML (20UNITS/ML) |
| EUGIA PHARMA SPECIALITIES LTD | 214314 | AP (A-rated, therapeutically equivalent) | August 15, 2022 | 20UNITS/ML (20UNITS/ML) |
| FRESENIUS KABI USA LLC | 213206 | AP (A-rated, therapeutically equivalent) | May 26, 2023 | 20UNITS/ML (20UNITS/ML) |
| CIPLA LTD | 217987 | AP (A-rated, therapeutically equivalent) | December 6, 2023 | 20UNITS/100ML (0.2UNITS/ML) |
| GLAND PHARMA LTD | 216963 | AP (A-rated, therapeutically equivalent) | February 9, 2024 | 20UNITS/ML (20UNITS/ML), 40UNITS/100ML (0.4UNITS/ML) |
| DR REDDYS LABORATORIES LTD | 213988 | AP (A-rated, therapeutically equivalent) | May 8, 2024 | 20UNITS/ML (20UNITS/ML), 40UNITS/100ML (0.4UNITS/ML) |
| SANDOZ INC | 212069 | AP (A-rated, therapeutically equivalent) | May 6, 2026 | 200UNITS/10ML (20UNITS/ML) |
| SANDOZ INC | 212068 | AP (A-rated, therapeutically equivalent) | May 6, 2026 | 20UNITS/ML (20UNITS/ML) |
Vasostrict patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9744209 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9375478 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9744239 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9687526 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9750785 | January 30, 2035 | Drug product | None | 204485 |
| 10010575 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9981006 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9974827 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9968649 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9962422 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9925234 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 9925233 | January 30, 2035 | Method of use | U-1857 | 204485 |
| 12186362 | January 30, 2035 | Drug product | None | 204485 |
| 9919026 | January 30, 2035 | Drug product | None | 204485 |
| 9937223 | January 30, 2035 | Method of use | U-1857 | 204485 |
Vasostrict NDC codes
Questions
Is there a generic for Vasostrict?
Yes. The generic name for Vasostrict is vasopressin. 8 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP. Generics match 4 of the 6 Vasostrict products the Orange Book lists.
What is the generic name for Vasostrict?
The active ingredient in Vasostrict is vasopressin, per the FDA Orange Book.
When does the Vasostrict patent expire?
The last patent listed for Vasostrict in the Orange Book expires January 30, 2035. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.